article · Biointerface Research in Applied Chemistry
New mono- and bimetallic copper, zinc, and cobalt complexes derived from the ligand 4-(benzo[d]thiazol-2-yl)-N, N-dimethylaniline (L) were successfully synthesized and characterized using UV-visible, FT-IR, 1H-NMR, 13C-NMR, mass spectrometry, and molar conductance measurements. The molar conductance data confirmed that all synthesized complexes are non-electrolytes. Spectroscopic analyses indicated that the ligand coordinates with the metal ions in a monodentate fashion through its nitrogen atom. The antioxidant activity of the ligand and its metal complexes was tested using the DPPH assay, revealing that complexation significantly enhanced radical scavenging ability. The Cu(II) complex exhibited the strongest activity with an IC₅₀ value of 0.008 ± 0.005 mg/mL, followed by Co(II) (0.014 ± 0.003 mg/mL), Zn(II) (0.024 ± 0.007 mg/mL), and the free ligand (0.043 ± 0.004 mg/mL), compared to ascorbic acid (0.046 ± 0.003 mg/mL). Antibacterial screening using the well-diffusion method on agar demonstrated that the metal complexes had greater inhibitory activity than the free ligand, particularly against Staphylococcus aureus and Pseudomonas aeruginosa, with minimum inhibitory concentration (MIC) values ranging from 0.25 to 1.0 mg/mL. Overall, this study reports the successful synthesis and comprehensive characterization of benzothiazole-based Schiff base metal complexes with markedly improved antioxidant and antibacterial properties, highlighting their potential as promising candidates for further pharmacological investigations.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.33263/briac161.012
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.